


New Mesothelioma Drug Fast Tracked by FDA
The immunotherapy drug ONCOS-102 has been granted Fast Track designation by the Food and Drug Administration (FDA). Fast Track designation speeds up the regulatory review process for the drug. What Is ONCOS-102? ONCOS-102 is an immune activator designed for pleural...
EPA Must Fully Protect Americans From Asbestos Exposure and Mesothelioma
In May of 2020, the Environmental Protection Agency (EPA) published a review of continuing dangers associated with asbestos, pursuant to the the amended Toxic Substances Control Act (TSCA). This risk evaluation was widely criticized by scientists and...
Asbestos is Hiding Everywhere
By: Andrew S. Wainwright Experienced Mesothelioma Lawyers Working for You Thornton Law Firm LLP has been representing victims of asbestos-related diseases and their families for decades. Through our cases representing workers with mesothelioma, lung cancer,...